Evidence map›Paper›PMID 38893769›Full record

ArticleMaterials (Basel, Switzerland)2024

Alumina Ceramics for Armor Protection via 3D Printing Using Different Monomers.

Dongjiang Zhang, Zhengang Liang, Xin Chen, Chunxu Pang, Xuncheng Guo, Xiqing Xu

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dongjiang ZhangSchool of Equipment Engineering, Shenyang Ligong University, Shenyang 110159, China.
Zhengang LiangSchool of Equipment Engineering, Shenyang Ligong University, Shenyang 110159, China.
Xin ChenSchool of Materials Science and Engineering, Chang'an University, Xi'an 710061, China.
Chunxu PangXi'an Modern Control Technology Research Institute, Xi'an 710065, China.
Xuncheng GuoXi'an Modern Control Technology Research Institute, Xi'an 710065, China.
Xiqing XuSchool of Materials Science and Engineering, Chang'an University, Xi'an 710061, China.

Funding

Key Research and Development Project of Shaanxi Province of China 2024GX-YBXM-398
6 · The paper itself

Abstract

Alumina ceramic is an ideal candidate for armor protection, but it is limited by the difficult molding or machining process. Three-dimensional printing imparts a superior geometric flexibility and shows good potential in the preparation of ceramics for armor protection. In this work, alumina ceramics were manufactured via 3D printing, and the effects of different monomers on the photosensitive slurry and sintered ceramics were investigated. The photosensitive slurries using dipropylene glycol diacrylate (DPGDA) as a monomer displayed the optimal curing performance, with a low viscosity, small volume shrinkage and low critical exposure energy, and each of the above properties was conducive to a good curing performance in 3D printing, making it a suitable formula for 3D-printed ceramic materials. In the 3D-printed ceramics with DPGDA as a monomer, a dense and uniform microstructure was exhibited after sintering. In comparison, the sample with trimethylolpropane triacrylate (TMPTA) showed an anisotropic microstructure with interlayer gaps and a porosity of about 9.8%. Attributed to the dense uniform microstructure, the sample with DPGDA exhibited superior properties, including a relative density of 97.5 ± 0.5%, a Vickers hardness of 19.4 ± 0.8 GPa, a fracture toughness of 2.6 ± 0.27 MPa·m

Indexed as

3D printingalumina ceramicsdynamic mechanical propertyinterlayer gapmonomer

Identifiers

PMID38893769
PMCPMC11172860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.